Abstract. We examined the effect of endothelin-3 (ET-3) at a high dose (pressor dose) and a low dose (non-pressor dose) in rat perfused kidney (PK), since ET-3 has recently been reported to exert a vasodilator action especially at a low dose. Kidneys were perfused with Krebs-Henseleit buffer at a fixed (saline; n=6), 10-13M ET-3 (low dose; n=6) or 10-8M ET-3 (high dose; n=6) was added to the perfusate, and sample collection was performed for the same period with each. The high dose of ET-3 significantly increased the perfusion pressure, fractional sodium excretion and synthesis of prostaglandins (PGs) consistently with a significant reduction in the glomerular filtration rate (GFR). On the other hand, the low dose of ET-3 significantly increased the GFR, urine volume and free-water clearance with no change in the perfusion pressure or synthesis of PGs. These findings suggest that a low dose of ET-3 can increase the glomerular capillary ultrafiltration coefficient and that ET-3 exerts an influence on sodium and water handing in the rat PK.
(Endocrinol Japon 38: 435-440, 1991) ENDOTHELIN-1 (ET-1), a potent vasoconstrictor peptide [1] , has been reported to play a possible role in the control of renal function through contraction of the renal vessels [2, 3] and contraction of glomerular mesangial cells [4] . The above studies demonstrated that a pressor dose of ET-1 induced a marked decrease in the glomerular differs from ET-1, has also been reported to be a vasoconstrictor peptide [5] . Recently, both ET-1 and ET-3 have been shown to exert a vasodilator effect at low doses, and ET-3 was found to be more selective than ET-1 as a vasodilator [6] . The present study was therefore undertaken to examine the effect of ET-3 at a low dose on the renal function of the rat perfused kidney (PK).
Materials and Methods
Perfusion of the kidney Male Wistar rats, aged 8-9 weeks and weighing 250-300g, were used. After anesthetizing the rats with pentobarbital sodium (100 mg/kg, i.p.), an abdominal incision was made. The left kidney was exposed and the aorta was cannulated with PE 50 tubing through the superior mesenteric artery without ischemia. The kidney was then continuously perfused in situ with Krebs-Henseleit buffer containing 1g/l glucose and 1g/l inulin at a eliminator (Pall Biomedical Inc., USA) with a micro-tube pump (MP-3, Tokyo Rikakikai Co., Ltd., Japan). After commencing perfusioin, the 
Discussion
The present results show that ET-3 at a low dose (non-pressor dose) can significantly increase the GFR, but at a high dose (pressor dose) it markedly reduced the GFR in the rat PK. Cairns et al. reported the possibility that ET-1 at a pressor dose reduced the GFR by vasoconstriction of the afferent glomerular vessels in the rabbit PK [10] . We also observed a large increase in perfusion pressure with a reduction in the GFR following infusion of a high dose of ET-3, suggesting contraction of the renal arteries. Badr et al. demonstrated a marked fall in the glomerular capillary ultrafiltration coefficient (Kf) and a contraction of mesangial cells consistently with a reduction in Kf in rats [4] . Furthermore, King et al.
found that the reduction in GFR caused by ET-1 depended on a reduction in Kf rather than a vasoconstricion [11] . We were unable to clarify whether or not ET-3 at a high dose had constricted the mesangial cells in the present study. However, it seems likely that ET-3 has similar effects to ET-1 on renal function, and similar mechanisms are probably evoked by ET-3 and contribute to a reduction in GFR. It is difficult to establish why an increase in GFR occurred following ET-3 infusion at a low dose in the rat PK. It appears unlikely that a change in transcapillary oncotic pressure following perfusion with albumin-free perfusate could contribute to the increase in GFR, since we observed no difference between GFR before and after infusion of the vehicle. Changes in the perfusion pressure and flow rate can also be excluded as explanatory factors, since ET-3 did not alter the perfusion pressure at a low dose and the kidneys were perfused at a fixed flow rate in the present study. We suspect therefore that a low dose of ET-3 may increase the GFR through an increase in Kf, although it remains unclear whether an increase in Kf can be induced by an increase in the effective hydraulic permeability of the capillary wall or by an enlargement of the total surface area available for filtration, which is suspected to be caused by a relaxation of the mesangial cells. Another possibility is that a low dose of ET-3 might induce vasodilatation in favor of the afferent glomerular vessels, which may be able to increase the transcapillary hydraulic pressure gradient without a change in the perfusion pressure. Warner et al. reported that ET-3 at a low dose (0.1-3 pmol) exhibited mainly vasodilatation by release of endothelium-derived relaxing factor in the rat mesentery [6] . This discrepancy between the failure of vasodilatation after the infusion of a low dose of ET-3 in our study and the vasodilatation in their report seems unlikely to depend on differences in organ-response to ET-3, since we observed initial vasodilatation with ET-3 at a high dose. It is possible therefore that a lower dose of ET-3 may elicit intrarenal vasodilation without affecting the overall renal vascular resistance, which results in an increase in GFR. The observed increase in FENa induced by a high dose of ET-3 might have reflected the glomerulotubular balance to some degree [ 12] . However, we consider that the pressure natriuresis which is thought to be caused by the increase in the hydraulic pressure in a peritubular capillary in consequence of the high perfusion pressure following the infusion of a high dose of ET-3 mainly increase the FENa, since there was no change in the perfusion pressure and FENa after infusion of the vehicle or a low dose of ET-3. We also observed marked increases in PGs in the renal venous effluent only after the infusion of a high dose of ET-3. Such findings are consistent with the reports of de Nucci et al. and Rae et al. who found that ET-1 at a pressor dose stimulated the release of PGs [ 13, 14] . Zeidel et al. further indicated that ET-1 inhibited Na+-K+-ATPase in the renal tubular epithelial cells by stimulating the synthesis of PGE2 [ 15] . We consider therefore that tubular factors must also be involved in the increase in FENa seen after the infusion of a high dose of ET-3 by means of the natriuretic action of PGs [ 16, 17] . But, we could not clarify the mechanism of PGs generation or the role of TXA2 in sodium handling after the infusion of a high dose of ET-3 in the rat PK. The high FENa values in our study might have been caused by the perfusion with albumin-free perfusate, since Firth et al. and Zamlauski-Tucker and Cohen found that a marked increase in FENa was observed when kidneys were perfused with albumin-free perfusate [18, 19] . The sodium excretion depends approximately on the GFR in the present study, suggesting that the potent effect of ET-3 on the GFR defeats the contribution of the tubuloglomerular feedback to control of the GFR. In addition,
we noted an increase in free-water clearance following infusion of ET-3 at a low dose, suggesting that ET-3 has an action on the water handling in the tubules including the collecting ducts. This might be partially supported by previous evidence indicating that ET-3 exists in the rat kidney inner medulla [20] . However, the mechanisms involved in the disappearance of an increase in free-water clearance after infusion of a high dose of ET-3 remain obscure.
The above data suggest that a low dose of ET-3
can increase the GFR without changes in perfusion pressure or PG synthesis, suggesting an increase in Kf in the rat PK. However, the detailed mechanisms involved in the tubular action of ET-3 remain to be elucidated.
